GOLDMAN SACHS GROUP INC - AVANIR PHARMACEUTICALS INC ownership

AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 114 filers reported holding AVANIR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$6,958,000
-64.5%
410,476
-75.0%
0.00%
-66.7%
Q3 2014$19,610,000
+272.2%
1,645,185
+76.1%
0.01%
+500.0%
Q2 2014$5,269,000
-52.8%
934,255
-69.3%
0.00%
-75.0%
Q1 2014$11,159,000
+125.8%
3,040,582
+106.7%
0.00%
+300.0%
Q4 2013$4,943,000
+598.2%
1,471,241
+779.0%
0.00%
Q3 2013$708,000
-29.2%
167,381
-23.0%
0.00%
Q2 2013$1,000,000
+609.2%
217,376
+303.8%
0.00%
Q4 2012$141,000
-73.9%
53,839
-68.1%
0.00%
Q3 2012$540,000
+23.0%
168,628
+50.5%
0.00%
Q2 2012$439,000
+177.8%
112,009
+142.1%
0.00%
Q1 2012$158,00046,2670.00%
Other shareholders

There were no reported owners of AVANIR PHARMACEUTICALS INC in Q2 2014.

NameSharesValueWeighting ↓
View complete list of AVANIR PHARMACEUTICALS INC shareholders